Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Win: Senate Votes To Continue Suspension of Medicare Sequester Cut through 2021

Mar 26, 2021/News

The compromise bill is likely to make it into law, but a lag in enactment could cause some logistical challenges.

APTA-CAPTE Joint Statement on Advancing Physical Therapy Education Accreditation

Mar 29, 2021/Statement

The statement is a promising first step to further enhance an already strong connection between the two organizations.

Defensive Contracting: Extrapolation, E-Payment, and Virtual Credit Cards

Mar 30, 2021/Article

A quick explanation of two payer activities that you may encounter in a contract: what they are, what to look for, and what you can do.

Won't Back Down: PTs, PTAs, Achieve Their Specialist, Proficiency Goals in 2020

Mar 30, 2021/News

In a challenging year, more than 3,000 PTs and PTAs earned a certification, were recertified, or achieved PTA advanced proficiency.

An On-the-Nose Career

Apr 1, 2021/Podcast

Defining Moment: Reminiscences of a PT and mother.

Chronic Pain: Time To Embrace the Big Three

Mar 31, 2021/Perspective

Physical therapy is ideally placed to take on the three main tenets of pain treatment and meaningfully impact the lives of patients.

In a Few Minutes, Access a Wealth of Financial Resources

Apr 9, 2021/Perspective

APTA is here to help you take control of your financial future.

Researchers: Physical Inactivity Impacts a Host of Noncommunicable Diseases

Apr 12, 2021/Review

A global study links significant percentages of dementia, depression, cancer, and stroke to insufficient PA.

Proposed FY '22 IRF Rule: 2.2% Increase; Call for Input on Equity, Reporting

Apr 13, 2021/Review

As the U.S. health care system continues to struggle with a pandemic and its fallout, CMS keeps IRF payment changes relatively minimal.

Regulatory and Advocacy Update, April 2021

Apr 14, 2021/Podcast

This episode: telehealth legislation, information blocking, and more.